Skip to Main Content

Several big drugmakers — Sanofi, GSK, Pfizer and Boehringer Ingelheim — will not have to face thousands of lawsuits claiming the Zantac heartburn drug can cause cancer after a federal judge decided consumers’ claims were not backed by sound scientific evidence.

In a 341-page ruling, U.S. District Court Judge Robin Rosenberg concluded that the consumer lawsuits relied on flawed science and were therefore unable to show legitimate links between the widely used medicine and several different cancers, including liver, bladder, and stomach cancer.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment